心臟去顫器市場規模、佔有率、成長分析、按類型、最終用途、按地區 - 產業預測，2025-2032 年

Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type (Implantable Cardioverter Defibrillators, External Cardioverter Defibrillators), By End Use (Hospitals, Pre-Hospital), By Region - Industry Forecast 2025-2032

出版日期: 2024年12月25日 | 出版商:

SkyQuest | 英文 224 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023年全球心臟去顫器市場規模為151億美元，從2024年的161.7億美元成長到2032年的280億美元，複合年成長率預計為7.1%。

由於產品技術的進步、公眾意識的提高以及心臟麻痹停發生率的增加，全球心臟去顫器市場預計將大幅成長。影響因素包括以吸煙為特徵的不健康生活方式、久坐的生活方式和肥胖。中國、印度和巴西等新興市場的心臟麻痹病例大幅增加，進一步推動了市場擴張。政府的措施和醫療機構對抗心血管疾病的努力也在推動這些救生設備的需求方面發揮著重要作用。隨著全球對有效心臟急救解決方案的需求持續成長，這些因素共同支持了心臟去顫器市場的強勁前景。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
收益與前一年同期比較（2022-2024）

主要企業簡介

Medtronic PLC
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
LivaNova PLC
Stryker Corporation
Koninklijke Philips NV
Cardiac Science Corporation
Zoll Medical Corporation
Nihon Kohden Corporation
Schiller AG
Fukuda Denshi Co.
Mediana Co., Ltd.
Defibtech LLC
Physio-Control（Stryker Corporation）

結論和建議

簡介目錄

Product Code: SQMIG35A2207

Global Cardioverter Defibrillator Device Market size was valued at USD 15.1 billion in 2023 and is poised to grow from USD 16.17 billion in 2024 to USD 28 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global cardioverter defibrillator market is poised for significant growth driven by advancements in product technology, heightened public awareness, and rising incidences of sudden cardiac arrest. Contributing factors include unhealthy lifestyles characterized by smoking, sedentary habits, and obesity. Emerging markets such as China, India, and Brazil are experiencing a notable increase in cardiac arrest cases, further propelling market expansion. Government initiatives and efforts by healthcare organizations to combat cardiovascular diseases are also playing a crucial role in driving demand for these life-saving devices. Together, these elements underscore a robust market outlook for cardioverter defibrillators as the need for effective cardiac emergency solutions continues to grow globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardioverter Defibrillator Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardioverter Defibrillator Device Market Segmental Analysis

Global Cardioverter Defibrillator Device Market is segmented by type, end use and region. Based on type, the market is segmented into implantable cardioverter defibrillators and external cardioverter defibrillators. Based on end use, the market is segmented into hospitals, pre-hospital, public access market, alternative care and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardioverter Defibrillator Device Market

The global Cardioverter Defibrillator Device market is significantly driven by technological advancements in these life-saving devices, leading to improvements in cost-effectiveness, compactness, and user-friendliness. Innovations such as automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs) have enhanced their efficacy in managing cardiac emergencies. With proper training, laypersons can operate these devices with ease, making them more accessible in critical situations. Additionally, the rising incidence of cardiovascular conditions, including arrhythmias and heart failure, is fueling market demand, as noted by the World Health Organization, which identifies cardiovascular diseases as a leading global cause of mortality.

Restraints in the Global Cardioverter Defibrillator Device Market

The global cardioverter defibrillator device market faces significant restraints that hinder its growth potential. One primary challenge is the high cost associated with these devices, which can be prohibitive for patients from low-income backgrounds, potentially limiting their access to essential cardiac care. Moreover, the financial constraints faced by healthcare systems may further restrict the adoption rates of these vital devices in the future. Additionally, a shortage of skilled professionals, including electrophysiologists, cardiologists, and cardiac surgeons, exacerbates the situation, as the lack of expertise could lead to decreased utilization of heart defibrillators, ultimately impacting market expansion.

Market Trends of the Global Cardioverter Defibrillator Device Market

The Global Cardioverter Defibrillator Device market is witnessing a significant uptrend driven by the rise of smart pacemaker technology. These advanced devices enhance patient monitoring by detecting even subtle cardiac irregularities, promptly correcting them and providing real-time alerts to both patients and healthcare providers. This innovation not only improves patient outcomes but also contributes to decreasing mortality rates associated with cardiac issues. As healthcare systems increasingly embrace digital health solutions, the demand for smart pacemakers is expected to surge, propelling growth in the cardioverter defibrillator sector. Consequently, market players are focusing on technological advancements to meet evolving consumer needs.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Cardioverter Defibrillator Device Market Size by Type & CAGR (2025-2032)

Market Overview
Implantable Cardioverter Defibrillators
External Cardioverter Defibrillators

Global Cardioverter Defibrillator Device Market Size by End Use & CAGR (2025-2032)

Market Overview
Hospitals
Pre-Hospital
Public Access Market
Alternative Care
Others

Global Cardioverter Defibrillator Device Market Size & CAGR (2025-2032)

North America (Type, End Use)
- US
- Canada
Europe (Type, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoll Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fukuda Denshi Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediana Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Defibtech LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Physio-Control (Stryker Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments